SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001078782-16-003875
Filing Date
2016-11-30
Accepted
2016-11-29 18:40:14
Documents
64
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A AMENDED QUARTERLY REPORT f10qa093016_10qz.htm 10-Q/A 43609
2 EXHIBIT 31.1 SECTION 302 CERTIFICATION f10qa093016_ex31z1.htm EX-31.1 6050
3 EXHIBIT 32.1 SECTION 906 CERTIFICATION f10qa093016_ex32z1.htm EX-32.1 2840
  Complete submission text file 0001078782-16-003875.txt   2298047

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axim-20160930_cal.xml EX-101.CAL 9221
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axim-20160930_def.xml EX-101.DEF 31893
6 XBRL INSTANCE DOCUMENT axim-20160930.xml EX-101.INS 314153
7 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT axim-20160930_lab.xml EX-101.LAB 344031
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axim-20160930_pre.xml EX-101.PRE 194626
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axim-20160930.xsd EX-101.SCH 87398
Mailing Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022
Business Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-54296 | Film No.: 162023734
SIC: 2834 Pharmaceutical Preparations